Mortality, Resource Utilization And Inpatient Costs Vary Among Pediatric Heart Transplant Indications: A Merged Data Set Analysis From The United Network For Organ Sharing And The Pediatric Health Information Systems (UNOS-PHIS) Databases

Pediatric heart transplantation is considered a standard therapy for end-stage heart failure refractory to medical and surgical therapy.1 Since its inception in 1967, heart transplant use has continually increased with expansion to more complex populations.2,3 A recent International Society of Heart and Lung Transplantation (ISHLT) report evaluated post-transplant outcomes among different transplant indications and found that despite ongoing improvement in overall pediatric transplant survival, there remains a persistent survival advantage for dilated cardiomyopathy compared to congenital heart disease (CHD) and re-transplantation.

Source: Journal of Cardiac Failure - November 25, 2018 Category: Cardiology Authors: Danielle S. Burstein, Yimei Li, Kelly D. Getz, Yuan-Shung V. Huang, Joseph W. Rossano, Matthew J. O'Connor, Kimberly Y. Lin, Richard Aplenc Tags: Clinical Investigation Source Type: research